Physician profile
Sunil Singh
NPI 1710220181
$2,527.15
in general payments reported to CMS, 2019-2025
17 companies · $490 in 2025
The $490 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $279 · 2020: $41.99 · 2021: $113 · 2022: $173 · 2023: $736 · 2024: $694 · 2025: $490.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,909 · Education: $10.85.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,909.43 |
| Education | $10.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $786.92 | 2019-2024 | Xarelto |
| Novo Nordisk INC | $589.33 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Merck Sharp & Dohme LLC | $241.21 | 2023-2025 | Zerbaxa, Dificid, Zinplava |
| Pfizer INC. | $165.32 | 2019-2025 | |
| Mylan Specialty L.P. | $115.69 | 2022-2023 | Yupelri |
| Dentsply Sirona INC | $100.00 | 2023 | Primescan Connect |
| Axogen | $88.37 | 2022 | |
| Medtronic USA, INC. | $86.02 | 2019 | |
| Biomerieux INC | $77.48 | 2019 | |
| Novartis Pharmaceuticals Corporation | $67.35 | 2019-2024 | |
| Ucb, INC. | $55.17 | 2019-2024 | Briviact |
| Astrazeneca Pharmaceuticals LP | $48.37 | 2020-2023 | Lokelma |
| Fisher & Paykel Healthcare INC | $25.45 | 2024 | Fisher & Paykel Healthcare |
| Gilead Sciences, INC. | $22.82 | 2023 | Veklury |
| Medline Industries LP | $22.14 | 2023 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $18.22 | 2023 | Collagenase Santyl |
| Vapotherm INC | $17.29 | 2024 | Vapotherm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sunil Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.